Research
Hormonal
GLP-1 receptor agonists (e.g., Liraglutide 3.0mg) and SGLT2 inhibitors significantly reduce body weight and improve glycemic control in T2D patients, with GLP-1 agonists showing superior weight loss compared to other drug classes.
If lifestyle changes are not enough, ask your doctor about GLP-1 receptor agonists (like Liraglutide) or SGLT2 inhibitors. These drugs help you lose weight and control blood sugar, unlike older diabetes medications that cause weight gain. GLP-1s are particularly effective for weight loss.
StrongSupportsVERY_HIGH confidence
Агонисты рецепторов ГПП-1... ассоциируются со значительным снижением массы тела... Ингибиторы натрий-глюкозных котранспортеров 2 типа (НГЛТ-2)... способствуют выведению из организма калорий, что приводит к снижению веса на 2 кг в среднем
Why this rating
Based on multiple RCTs and meta-analyses cited (SCALE, LEADER, EMPAREG-OUTCOME, CANVAS).
Source
Obesity and type 2 diabetes: can we find a compromised treatment solution?
G. R. Galstyan et al. · Diabetes Mellitus · 2017
narrative_reviewCited 18×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →